article_metadata: Hesham Abboud Adnan Subei Buse Sengul Robert K Shin Paige Goulette Rosemarie Walch Jeanie Coté Robert Pace Ahmed Z Obeidat Lisa Ferayorni Shervin Gholizadeh
article_metadata: 10.3389/fimmu.2024.1526563
article_metadata: Front Immunol
article_metadata: 2025 Jan 10:15:1526563.
article_metadata: aqp4 nmosd case series eculizumab satralizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39867894/
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Aquaporin 4 / immunology Immunoglobulin G / blood Neuromyelitis Optica / drug therapy Neuromyelitis Optica / immunology
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Aquaporin 4 / immunology Immunoglobulin G / blood Neuromyelitis Optica / drug therapy Neuromyelitis Optica / immunology Case Reports Adult Aged Aged, 80 and over Autoantibodies / blood Autoantibodies / immunology Female Humans Male Middle Aged Treatment Outcome eculizumab Antibodies, Monoclonal, Humanized Aquaporin 4 Immunoglobulin G AQP4 protein, human Autoantibodies
article_metadata: PMC11757099
article_metadata: 39867894
article_metadata: Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report
article_metadata: 2025